Effect of drugs on mnestic performance: A methodological approach

Human Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 11-19

  Allain, Hervé ^a   Lieury, Alain ^b   Belliard, Serge ^a   Caldwell, Maeve ^a   Patat, Alain ^c   Gandon, Jean Marc ^c  

^a Faculty of Law   (France)

^b UNIVERSITÉ RENNES 2   (France)

^c Biotrial SA   (France)

Author keywords

Clinical trials; Drugs; Memory; Methodology; Psychometry; Psychotropic

Indexed keywords

ANTIDEPRESSANT AGENT; BROMAZEPAM; NOOTROPIC AGENT; TRANQUILIZER;

ANIMAL MODEL; ARTICLE; BEHAVIOR; COGNITION; HUMAN; HUMAN EXPERIMENT; LEARNING; MEMORY; MENTAL PERFORMANCE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHARMACOLOGY;

EID: 0030063835     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199601)11:1<11::AID-HUP734>3.0.CO;2-K     Document Type: Article

References (63)

1. Allain, H. and Reymann, J. M. (1994). Dix ans passés en Psychoparmacologie. Synapse, 103, 71-75.
2. Allain, H., Bentue-Ferrer, D. and Decombe, R. (1990a). Choosing a target for cognitive enhancers. Clinical Therapeutics, 12, 108-114.
3. Allain, H., Decombe, R., Reymann, J. M., Martinet, J. P. and Lieury, A. (1990b). La pharmacologie de la mémoire: un état des lieux. Psychological Medicine (Paris), 22, 1261-1263.
4. Allain, H., Lieury, A., Reymann, et al. (1990c). Le développement de médicaments pro-mnésiants. Ann. Méd. Interne, 141, (suppl. 1), 19-25.
5. Allain, H., Lieury, A. and Gandon, J. M. (1992a). Psychotropic drugs and cognitive functions: the antidepressant example. Focus on Depression, 3, 34-37.
6. Allain, H., Lieury, A., Brunet-Bourgin, et al. (1992b). Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology, 106, S56-S61.
7. Allain, H., Lieury, A., Bureau. M. and Gandon, J. M. (1992c). Zopiclone et processus mnésiques. In: Zopiclone 1987-1992: 5 Années de Pratique Clinique, Grivois, H., et al. (Eds), Elsevier, Paris, pp. 93-116.
8. Allain, H., Lieury, A. and Gandon, J. M. (1993a). Psychopharmacology of memory components. In: Human Psychopharmacology 1993, Vol. 4, Hindmarch, I. and Stonier, (Eds), Johns Wiley and Sons, pp. 143-164.
9. Allain, H., Raoul, P., Lieury, A., Le Coz, F. and Gandon, J. M. (1993b). Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual coding test in elderly subjects. Clinical Therapeutics, 15, 549-558.
10. Allain, H., Neuman, E., Wesnes, K., Gandon, J. M., Malbezin, M. and Guez, D. (1994). Effets cliniques et acceptabilité d'un traitement par le SI 12024-2 chez 53 patients ayant une démence de type Alzheimer d'intensité modérée à sévère. Essai randomisé en double aveugle contre placebo sur 28 jours. In: Actualites sur la Malade d'Alzheimer et les Syndromes Appareutes. M. Poncet, B. Michel and A. Nieoullon (Eds). Solal Edition, Marseille, France.
11. Bekkers, J. M. (1993). Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science, 261, 104-105.
12. Clark, C. R., Geffen, G. M. and Geffen, L. B. (1986). Role of monoamine pathways in the control of attention. Effects of droperidol and methylphenidate in normal adult humans. Psychopharmacology, 90, 28-34.
13. Curran, H. V., Sakulsriprong, M. and Lader, M. (1988). Antidepressant and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology, 4, 520-527.
14. Danion, J. M., Durand, D. E., Bousingen, R., Zimmerman, M. A., Willard-Schroeder, D. and Singer, L. (1988). Les troubles de ia mémoire en pratique médicale: données cliniques et psychologiques actuelles. Ann. Psychiatr. 3, 373-380.
15. Derouesne, Ch. (1989). Les troubles de la mémoire du sujet âgé. Sem. Hôp. Paris, 65, 2304-2306.
16. Derouesne, Ch., Alperovitch, A., Boyer, P. et al. (1992). Performances cognitives objectives et plaintes mnésiques. Psychologe Medical (Paris), 24, 1075-1085.
17. Dickson, C. T. and Vanderwolf, C. H. (1990). Animal models of human amnesia and dementia: hippocampal and amygdala ablation compared with serotonergic and cholinergic blockade in the rat- Behav. Brain Res., 41, 215-227.
18. Doyle, E. and Regan, C. M. (1993). Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM sialylation state. J. Neural. Transm. Gen. Sect., 92, 33-49.
19. Doyle, E., Regan, C. M. and Shiotani, T. (1993). Nefiracetam (DM 9384) preserves hippocampal neural cell adhesion molecule-mediated memory consolidation processes during scopolamine disruption of passive avoidance training in the rat. Journal of Neurochemistry, 61, 266-272.
20. Engelsmann, F., Ghadirian, A. and Grof, P. (1992). Lithium treatment and memory assessment: methodology. Neuropsychobiology, 26, 113-119.
21. Eustache, F., Desgranges, B. and Lechevalier, (1989). Les méthodes d'exploration de la mémoire en clinique chez l'adulte. Neuro-Psy, 4, 50-61.
22. Ghoneim, M. M. and Block, R. I. (1992). Learning and consciousness during general anesthesia. Anesthesiology, 76, 279-305.
23. Ghoneim, M. M. and Mewaldt, S. P. (1990). Benzodiazepines and human memory: a review. Anesthesiology, 72, 926-938.
24. Gluck, M. A. and Granger, R. (1993). Computational models of the neural bases of learning and memory. Annual Review of Neurosciences, 16, 667-706.
25. Goldman-Rakic, P. S. (1994). The issue of memory in the study of prefrontal function. In: Motor and Cognitive Functions of the Prefrontal Cortex, Thierry, A. M. et al. (Eds), Springer-Verlag, Berlin, pp. 112-121.
26. Grover, L. and Teyler, T. (1990). Two components of long-term potentiation induced by different patterns of afferent activation. Nature, 347, 477-479.
27. Heiss, W. D., Pawlik, G. Holthoff, V., Kessler, J. and Szelies, B. (1992). PET correlates of normal and impaired memory functions. Cerebrovascular and Brain Metabolism Review, 4, 1-27.
28. Huston, J. P., Hasenohrl, R. U., Boix, F. N., Gerhardi, P. and Schwarting, R. K. W. (1993). Sequence-specific effects of neurokinin substance P on memory, reinforcement and brain dopamine activity. Psychopharmacology, 112, 147-162.
29. Jaffard, R. (1988). Modèles animaux de la mémoire et des amnésies. Neuro-Psy, 3, 19-27.
30. Jaffe, K., Zabala, N., De Bellard, M. et al. (1990). Amino-acids and memory consolidation in the cricket II: Effect of injected amino-acids and opioids on memory. Pharmacology, Biochemistry and Behaviour, 35, 133-136.
31. King, D. J. (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799-811.
32. Knowlton, B. J. and Squire, L. R. (1993). The learning of categories: parallel brain systems for item memory and category knowledge. Science, 262, 1747-1749.
33. Krupa, D. J., Thompson, J. K. and Thompson, R. F. (1993). Localisation of a memory trace in the mammalian brain. Science, 260, 989-991.
34. Lhermitte, F., Derouesne, Ch. and Signoret, J. L. (1972). Analyse neuropsychologique du syndrome frontal. Rev. Neurol., 127, 415-440.
35. Lieury, A. (1993). La Mémoire. Martaga Editeur, 4e edition, Bruxelles 1993.
36. Lieury, A., Raoul, P., Boujon, Ch., Bernoussi, M. and Allain, H. (1991). Le vieillissement des composants de la mémoire: analyse factorielle de 17 scores de mémoire. L'Année Psychol. (Paris), 91, 169-186.
37. Light, L. L. (1991). Memory and aging: form hypothesis in search of data. Annual Review of Psychology, 42, 333-376.
38. Martignoni, E., Costa, A., Sinforiani, E. et al. (1992). The brain as a target for adrenocortical steroids: cognitive implication. Psychoneuroendocrinology, 17, 343-354.
39. Martinet, J. P., Reymann, J. M., Lieury, A. and Allain, H. (1989). La pharmacologie de la mémoire. Neuro-Psy, 4, 33-49.
40. McAinsh, J. and Cruikshank, J. M. (1990). Beta blockers and central nervous system side effects. Pharmacology and Therapeutics, 46, 163-197.
41. McDonald, R. J. and White, N. M. (1993). A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav. Neurosci., 107, 3-22.
42. Moran, P. M., Lemaitre, M. H., Philouze, V., Reymann, J. M., Allain, H. and Leonard, B. E. (1992). Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP 4 in the rat. Brain Research, 595, 327-333.
43. Newman, R. P., Weingartner, H., Smallberg, S. A. and Calne, D. (1984). Effortful and automatic memory: effects of dopamine. Neurology, 34, 805-807.
44. Pandit, S., Dundee, J. W. and Keilty, S. R. (1971). Amnesic studies with intravenous premedication. Anaesthésia, 26, 421-428.
45. Pardo, J. V., Fox, P. T. and Raichle, M. E. (1991). Localisation of a human system for sustained attention by positon emission tomography. Nature, 349, 61-64.
46. Raoul, P., Lieury, A., Decombe, R., Chauvel, P. and Allain, H. (1992). Déficit mnésique au cours de la maladie de Parkinson. Presse Med. (Paris), 21, 69-72.
47. Résumé (1991). Une nouvelle forme de potentialisation à long terme au niveau de l'hippocampe. Médecine/ Sciences, 7, 80-82.
48. Sarter, M. (1991). Taking stock of cognition enhancers. Trends in Pharmacological Sciences, 12, 456-461.
49. Sarter, M., Hagan, J. and Dudchenko, T. (1992). Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacology, 111, 167-172.
50. Scamman, F. L., Ghoneim, M. M. and Kortilla, K. (1984). Ventilatory and mental effects of alfentanyl and fentanyl. Act. Anaesthesiol. Scand., 28, 63-67.
51. Schulteis, G. and Martinez, J. L. (1992). Peripheral modulation of learning and memory: enkephalins as a model system. Psychopharmacology, 109, 347-364.
52. Service, R. F. (1993). Making modular memories. Science, 260, 1876.
53. Squire, L. R. (1986). Mechanisms of memory. Science, 232, 1612-1619.
54. Squire, L. R., Knowlton, B. and Musen, G. (1993). The structure and organization of memory. Annual Review of Psychology, 44, 453-495.
55. Thompson, P. (1992). Antiepileptic drugs and memory. Epilepsia, 33, S37-S40.
56. Tulving, E. (1985). How many memory systems are there? American Psychology, 40, 385-398.
57. Ungerer, A., Mathis, C., Melan, C. and De Barry, J. (1990). Rôle des acides amines neuroexcitateurs dans les phénomènes de mémoire. Etude à partir de l'acide γ-L-glutamyl-L-aspartique. L'Encéphale, XVI, 423-429.
58. Wilson, F. A. W., Scalaidhe, S. P. O. and Goldman-Rakic, P. S. (1993). Dissociation of object and spatial processing in primate prefrontal cortex. Science, 260, 1955-1958.
59. Wippich, W. (1992). Implicit and explicit memory without awareness. Psych. Res., 54, 212-224.
60. Wittenborn, J. R. (1988). Assessment of the effects of drugs on memory. In: Benzodiazepine Receptor Ligands, Memory and Information Processing Psychometric and Psychopharmacological Issues, Hindmarch, I. and Ott, H. (Eds), Springer Verlag, Berlin, pp 67-78.
61. Wolkowitz, O. M., Reus, V. I., Weingartner, H. et al. (1990). Cognitive effects of corticosteroids. American Journal of Psychiatry, 147, 1297-1303.
62. Zhuo, M., Small, S. A., Kandel, E. R. and Hawkins, R. D. (1993). Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science, 260, 1946-1949.
63. Zola-Morgan, S. and Squire, L. R. (1993). Neuroanatomy of memory. Annual Review of Neuroscience, 16, 547-563.